Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
QNCX
QNCX News & Events
-
Add to Watchlist
Trade QNCX Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
QNCX News
Quince Therapeutics Acquires Orphai Therapeutics to Expand Pipeline
May 18 2026
seekingalpha
LAM-001 Shows Significant Efficacy in PH-ILD Patients
May 18 2026
Globenewswire
LAM-001 Shows Significant Efficacy in PH-ILD Patients
May 18 2026
Newsfilter
Quince Acquires Orphai to Advance LAM-001 Development
May 18 2026
Globenewswire
LAM-001 Shows Significant Efficacy in PH-ILD Patients
May 18 2026
Globenewswire
Quince Acquires Orphai to Advance Pulmonary Disease Treatments
May 18 2026
Newsfilter
Quince Therapeutics Releases Phase 2a Data for LAM-001 in PH-ILD Patients
May 18 2026
Newsfilter
Quince Therapeutics Settles Debt Obligations, Shares Rise
Mar 30 2026
NASDAQ.COM
Show More News
QNCX Events
No data
QNCX Monitor News
Quince Therapeutics Inc stock rises amid market decline
May 18 2026
Quince Therapeutics Inc stock rises after crossing above SMA
Apr 16 2026
Quince Therapeutics stock rises after crossing above SMA
Apr 10 2026
Quince Therapeutics Inc stock drops significantly
Apr 09 2026
Quince Therapeutics settles debt obligations, enhancing financial flexibility
Apr 06 2026
Quince Therapeutics Settles Debt, Enhances Strategic Flexibility
Apr 02 2026
Quince Therapeutics Settles Debt, Enhances Strategic Flexibility
Mar 31 2026
Quince Therapeutics stock surges amid market gains
Mar 30 2026
Show More Monitor News
QNCX Earnings Analysis
No Data
People Also Watch
